Coty Inc. has reported strong second quarter fiscal year 2026 results, showing continued momentum across its Prestige and Consumer Beauty segments as international markets and premium fragrance demand drove solid sales and profit growth.
The beauty giant posted revenue of $1,678.6 million increased, marking a 1% like for like increase, reflecting balanced growth across both divisions and all major regions. According to the company’s release, this performance was particularly propelled by expanding luxury fragrance sales and robust gains in Europe and the Middle East.
Prestige Beauty Leads Growth
The Prestige business continued to outperform expectations, delivering a 7% like for like increase driven by blockbuster fragrance launches and strong momentum in skin and body care. The company noted that this segment remains a cornerstone of its growth strategy, now accounting for over 60% of total sales.
“I’m truly excited and energized to join Coty at this pivotal moment,” said Markus…
Strobel, Executive Chairman and Interim Chief Executive Officer. Fragrance remained the company’s strongest performer, highlighting hits from Burberry Goddess, Gucci Flora, and Chloé Atelier des Fleurs.
New fragrance launches continue to play a key role in Coty’s brand portfolio expansion and pricing power, as luxury consumers continue to prioritize premium scents worldwide.
Consumer Beauty Returns to Stability The Consumer Beauty division also demonstrated ongoing stability with a 3% like for like increase in sales, supported by stronger performances from mass fragrance and color cosmetics.
Gains in this category were led by improvements in CoverGirl, Max Factor, and Rimmel, supported by bestselling mascara and foundation innovations…
Members-only article
Unlock the rest of this story
Join free to keep reading RetailBoss news coverage, industry analysis, and market intelligence.
- Full article access
- Industry analysis
- Free account
Free access. No credit card required. Your account is created after you verify your email.
Discussion
0 Comments
No comments yet
Start the conversation
Share your take on this story and help shape the discussion.
Sign in to join the discussion.